Unknown

Dataset Information

0

Comparison of clinical and molecular characteristics of patients with acute myeloid leukemia and either TP73 or TP53 mutations.

ABSTRACT:

SUBMITTER: Mims AS 

PROVIDER: S-EPMC7862425 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Clinical implications of subclonal TP53 mutations in acute myeloid leukemia.
| S-EPMC6395341 | biostudies-literature
Unknown Functional Classification of TP53 Mutations in Acute Myeloid Leukemia.
| S-EPMC7139772 | biostudies-literature
Unknown TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes.
| S-EPMC5269552 | biostudies-literature
Unknown Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine.
| S-EPMC7529302 | biostudies-literature
Unknown <i>TP53</i> Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
| S-EPMC7897660 | biostudies-literature
Unknown Characteristics of <i>DNMT3A</i> mutations in acute myeloid leukemia.
| S-EPMC7106122 | biostudies-literature
Unknown Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations.
| S-EPMC5060024 | biostudies-literature
Unknown Frequency of TP53 Mutations and its Impact on Drug Sensitivity in Acute Myeloid Leukemia?
| S-EPMC3358364 | biostudies-literature
Unknown <i>TP53</i> in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation.
| S-EPMC8509740 | biostudies-literature
Unknown Targeting acute myeloid leukemia with TP53-independent vosaroxin.
| S-EPMC5144553 | biostudies-literature